608 related articles for article (PubMed ID: 16818868)
21. Effects of Alzheimer disease on fronto-parietal brain N-acetyl aspartate and myo-inositol using magnetic resonance spectroscopic imaging.
Zhu X; Schuff N; Kornak J; Soher B; Yaffe K; Kramer JH; Ezekiel F; Miller BL; Jagust WJ; Weiner MW
Alzheimer Dis Assoc Disord; 2006; 20(2):77-85. PubMed ID: 16772742
[TBL] [Abstract][Full Text] [Related]
22. Developmental delay in children: assessment with proton MR spectroscopy.
Filippi CG; Uluğ AM; Deck MD; Zimmerman RD; Heier LA
AJNR Am J Neuroradiol; 2002 May; 23(5):882-8. PubMed ID: 12006297
[TBL] [Abstract][Full Text] [Related]
23. Proton magnetic resonance spectroscopy of late-life major depressive disorder.
Chen CS; Chiang IC; Li CW; Lin WC; Lu CY; Hsieh TJ; Liu GC; Lin HF; Kuo YT
Psychiatry Res; 2009 Jun; 172(3):210-4. PubMed ID: 19303260
[TBL] [Abstract][Full Text] [Related]
24. Quantitative proton MRS of Pelizaeus-Merzbacher disease: evidence of dys- and hypomyelination.
Hanefeld FA; Brockmann K; Pouwels PJ; Wilken B; Frahm J; Dechent P
Neurology; 2005 Sep; 65(5):701-6. PubMed ID: 16157902
[TBL] [Abstract][Full Text] [Related]
25. Metabolic brain mapping in Alzheimer's disease using proton magnetic resonance spectroscopy.
Lazeyras F; Charles HC; Tupler LA; Erickson R; Boyko OB; Krishnan KR
Psychiatry Res; 1998 May; 82(2):95-106. PubMed ID: 9754452
[TBL] [Abstract][Full Text] [Related]
26. A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age.
Chang L; Lee PL; Yiannoutsos CT; Ernst T; Marra CM; Richards T; Kolson D; Schifitto G; Jarvik JG; Miller EN; Lenkinski R; Gonzalez G; Navia BA;
Neuroimage; 2004 Dec; 23(4):1336-47. PubMed ID: 15589098
[TBL] [Abstract][Full Text] [Related]
27. Metabolite alterations in the hippocampus of high-functioning adult subjects with autism.
Suzuki K; Nishimura K; Sugihara G; Nakamura K; Tsuchiya KJ; Matsumoto K; Takebayashi K; Isoda H; Sakahara H; Sugiyama T; Tsujii M; Takei N; Mori N
Int J Neuropsychopharmacol; 2010 May; 13(4):529-34. PubMed ID: 19895725
[TBL] [Abstract][Full Text] [Related]
28. Metabolite profile in the basal ganglia of children with cerebral palsy: a proton magnetic resonance spectroscopy study.
Kulak W; Sobaniec W; Smigielska-Kuzia J; Kubas B; Walecki J
Dev Med Child Neurol; 2006 Apr; 48(4):285-9. PubMed ID: 16542516
[TBL] [Abstract][Full Text] [Related]
29. Biochemistry of the cingulate cortex in autism: An MR spectroscopy study.
Libero LE; Reid MA; White DM; Salibi N; Lahti AC; Kana RK
Autism Res; 2016 Jun; 9(6):643-57. PubMed ID: 26526126
[TBL] [Abstract][Full Text] [Related]
30. Proton magnetic resonance spectroscopic imaging of cortical gray and white matter in schizophrenia.
Lim KO; Adalsteinsson E; Spielman D; Sullivan EV; Rosenbloom MJ; Pfefferbaum A
Arch Gen Psychiatry; 1998 Apr; 55(4):346-52. PubMed ID: 9554430
[TBL] [Abstract][Full Text] [Related]
31. A repeat proton magnetic resonance spectroscopy study in social phobia.
Tupler LA; Davidson JR; Smith RD; Lazeyras F; Charles HC; Krishnan KR
Biol Psychiatry; 1997 Sep; 42(6):419-24. PubMed ID: 9285077
[TBL] [Abstract][Full Text] [Related]
32. Relationship between N-acetyl-aspartate in gray and white matter of abstinent methamphetamine abusers and their history of drug abuse: a proton magnetic resonance spectroscopy study.
Sung YH; Cho SC; Hwang J; Kim SJ; Kim H; Bae S; Kim N; Chang KH; Daniels M; Renshaw PF; Lyoo IK
Drug Alcohol Depend; 2007 Apr; 88(1):28-35. PubMed ID: 17084995
[TBL] [Abstract][Full Text] [Related]
33. Brain metabolic alterations in medication-free patients with bipolar disorder.
Dager SR; Friedman SD; Parow A; Demopulos C; Stoll AL; Lyoo IK; Dunner DL; Renshaw PF
Arch Gen Psychiatry; 2004 May; 61(5):450-8. PubMed ID: 15123489
[TBL] [Abstract][Full Text] [Related]
34. Detection of metabolites in the white matter of frontal lobes and hippocampus with proton in first-episode treatment-naïve schizophrenia patients.
He ZL; Deng W; Li ML; Chen ZF; Collier DA; Ma X; Li T
Early Interv Psychiatry; 2012 May; 6(2):166-75. PubMed ID: 21951785
[TBL] [Abstract][Full Text] [Related]
35. Supratentorial neurometabolic alterations in pediatric survivors of posterior fossa tumors.
Rueckriegel SM; Driever PH; Bruhn H
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1135-41. PubMed ID: 21658852
[TBL] [Abstract][Full Text] [Related]
36. Neurometabolite Alterations Associated With Cognitive Performance in Perinatally HIV-Infected Children.
Van Dalen YW; Blokhuis C; Cohen S; Ter Stege JA; Teunissen CE; Kuhle J; Kootstra NA; Scherpbier HJ; Kuijpers TW; Reiss P; Majoie CBLM; Caan MWA; Pajkrt D
Medicine (Baltimore); 2016 Mar; 95(12):e3093. PubMed ID: 27015179
[TBL] [Abstract][Full Text] [Related]
37. Biochemical alterations in multiple sclerosis lesions and normal-appearing white matter detected by in vivo 31P and 1H spectroscopic imaging.
Husted CA; Goodin DS; Hugg JW; Maudsley AA; Tsuruda JS; de Bie SH; Fein G; Matson GB; Weiner MW
Ann Neurol; 1994 Aug; 36(2):157-65. PubMed ID: 8053651
[TBL] [Abstract][Full Text] [Related]
38. Diffusion tensor spectroscopy (DTS) of human brain.
Ellegood J; Hanstock CC; Beaulieu C
Magn Reson Med; 2006 Jan; 55(1):1-8. PubMed ID: 16342152
[TBL] [Abstract][Full Text] [Related]
39. Reduced NAA in motor and non-motor brain regions in amyotrophic lateral sclerosis: a cross-sectional and longitudinal study.
Rule RR; Suhy J; Schuff N; Gelinas DF; Miller RG; Weiner MW
Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5(3):141-9. PubMed ID: 15512902
[TBL] [Abstract][Full Text] [Related]
40. Age-related change in brain metabolite abnormalities in autism: a meta-analysis of proton magnetic resonance spectroscopy studies.
Aoki Y; Kasai K; Yamasue H
Transl Psychiatry; 2012 Jan; 2(1):e69. PubMed ID: 22832731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
